Thomas F. DeLaney, M.D. is a graduate of Harvard College and Harvard Medical School. Following an internship in General Surgery at Yale-New Haven Hospital, he trained in Radiation Oncology at the Massachusetts General Hospital. He then spent 6 years as a Senior Investigator at the National Cancer Institute in Bethesda MD. Since 1992, he has been on the staff of the Massachusetts General Hospital and on the faculty of Harvard Medical School. Currently, he is the Medical Director of the Francis H. Burr Proton Therapy Center at Massachusetts General Hospital, Co-Director of the Center for Sarcoma and Connective Tissue Oncology at Massachusetts General Hospital, and Andres Soriano Professor of Radiation Oncology, Harvard Medical School.

Read More

Laura Dawson is a radiation oncologist at the Princess Margaret Cancer Centre, and a Professor the Department of Radiation Oncology, University of Toronto.  She completed her medical school and radiation oncology residency at the University of Toronto and a fellowship in high precision radiation therapy at the University of Michigan, where she stayed on as a faculty member until 2003, at which time she returned to Canada and developed a liver cancer radiation therapy program at the Princess Margaret Cancer Centre in Toronto.  She is an internationally recognized leader in hepatobiliary cancers, hepatic (and other) oligo-metastases and in the use of advanced radiation technologies, including stereotactic body radiation therapy (SBRT) and image guided radiation therapy (IGRT).

Read More

Luc Beaulieu is a full professor at Université Laval, Director of the CAMPEP graduate program and also Director of University Laval Cancer Research Centre. From 2010 to 2016, he served on the Board of the Canadian Organization of Medical Physicists as President Elect, President and Past President. Prof. Beaulieu is a recognized expert and an active researcher in the field scintillation dosimetry (with application to small field and in vivo dosimetry) and brachytherapy physics and technology.

Read More

Thomas Bortfeld, PhD, a physicist by training, is a Professor at the Harvard Medical School and serves as the Director of the Radiation Biophysics Division at the Massachusetts General Hospital.  He has been a primary developer of intensity-modulated radiation therapy (IMRT) and optimized “inverse” treatment planning. He and his team are refining IMRT through multi-criteria and robust optimization. Another research focus of his is in proton therapy. Recent research interests of his include imaging-guided temporo-spatial optimization of treatment dynamics, better ways to define the clinical target volume, and making the benefits of proton therapy available to more patients.

Melanie received her training in radiography and radiation therapy at the University of North Carolina-Chapel Hill.  She worked as a radiation therapist, medical dosimetrist and manager for more than 25 years before joining the faculty at Virginia Commonwealth University in 2006 as the radiation therapy program director. Melanie obtained her doctoral degree in 2015 from Virginia Commonwealth University in Education.

Tino Piscione joined the CMPA in July 2014, following 12 years as a staff pediatric nephrologist and clinician-scientist in the Department of Pediatrics at The Hospital for Sick Children and as an Assistant Professor of Pediatrics at the University of Toronto.  He graduated in medicine at Queen’s University in Kingston, Ontario in 1991.  He subsequently completed residency training in pediatrics and pediatric nephrology at The Hospital for Sick Children in Toronto in 1996.  His background in medical education stems from past experience as a associate and head program director of the Pediatric Nephrology Residency Training Program at the University of Toronto.  His interest in patient safety and quality improvement is founded on formal education in the Patient Safety & Quality Improvement Certificate Program at the University of Toronto.

Michael Brundage is a Professor of Oncology and of Public Health Sciences at Queen’s University at Kingston. He completed his training in Radiation Oncology at the University of Toronto and the Princess Margaret Hospital in Toronto, and in Epidemiology at Queen’s University, where he has enjoyed long-standing affiliations with the Canadian Clinical Trials Group and the Cancer Centre of Southeastern Ontario at Kingston General Hospital.

Read More

Michael Milosevic is a Professor in the Department of Radiation Oncology at the University of Toronto, a Radiation Oncologist at Princess Margaret Hospital and the Past-President of the Canadian Association of Radiation Oncology. His primary clinical interest is in the management of gynecologic cancer, and has been the Radiation Medicine Program Gynecologic Oncology Site Leader since 1997. His research revolves around the use of image-guided, adaptive, intensity modulated radiotherapy (IMRT) to treat cervix cancer. Other main research interest is the development of biology-based approaches to improving the effectiveness of radiotherapy, particularly in relation to tumour hypoxia and altered metabolism. He is a co-founder of the STTARR Research Program and the STTARR Innovation Centre in Toronto, which integrate molecular, cellular, animal and patient imaging with precision radiation research in a manner conducive to the rapid translation of novel treatment strategies from the laboratory to the clinical.

Brian Liszewski is a radiation therapist at Sunnybrook Health Sciences Centre’s Odette Cancer Centre. He is the Quality Assurance Coordinator for the Radiation Therapy Program as well as a Practice-Based Researcher at the Sunnybrook Research Institute and Lecturer, Department of Radiation Oncology, University of Toronto. He has a keen interest in quality serving on the Many Pan-Canadian committees such as the Canadian Partnership for Quality Radiotherapy (CPQR), Canadian Association of Radiation Oncolgy’s Quality and Safety Committee and the ESTRO Radiation Oncology Safety and Quality Committee.

Leigh Conroy completed her PhD in Radiation Oncology Physics at the University of Calgary in 2017 and is currently a Medical Physics Resident at Princess Margaret Cancer Centre. Her research interests are in resource-efficient treatment strategies, with a current focus in automation in radiotherapy.

Benjamin Haibe-Kains is a Senior Scientist at the Princess Margaret Cancer Centre (PM), University Health Network, and Associate Professor in the Medical Biophysics department of the University of Toronto. He earned his PhD in Bioinformatics at the Université Libre de Bruxelles (Belgium). Supported by a Fulbright Award, he did his postdoctoral fellowship at the Dana-Farber Cancer Institute and Harvard School of Public Health (USA). He started his own laboratory at the Institut de Recherches Cliniques de Montréal (Canada) and moved to PM in November 2013.

Read More

Wouter van Elmpt is senior scientist specialized in advanced image acquisition and analysis for cancer patients at the MAASTRO clinic, Maastricht (The Netherlands). He is also appointed at the Maastricht University as an assistant professor since January 2015. He holds a Master of Science degree in Applied Physics from the Eindhoven University of Technology (The Netherlands) and he obtained his PhD at the Maastricht University (The Netherlands) in 2009 in the field of radiotherapy treatment verification.

Read More

Jan P. Seuntjens (Ph.D, 1991, University of Ghent, Belgium) is a medical radiation physicist, full professor, James McGill research chair and director of medical physics at McGill University since 2009. He has a background in radiation physics and Monte Carlo (MC) numerical simulations and has been deeply involved in the experimental work behind calibration protocols such as AAPM TG-51 and its Addendum. More recently, he has been concentrating on the use of numerical techniques including MC and machine learning involved in different studies correlating imaging and dosimetric parameters with treatment outcome in radiation therapy.

Read More